Related Experiment Video

Updated: Aug 16, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
08:34

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

Congenital heart disease in relation to pulmonary hypertension in paediatric practice

Robert M R Tulloh1

  • 1Department of Congenital Heart Disease, Paul O'Gorman Building, Bristol Royal Hospital for Children, Upper Maudlin Street, Bristol BS2 8BJ, UK.

Paediatric Respiratory Reviews
|September 13, 2005
PubMed

Insights

Pulmonary hypertension (PHT) in congenital heart disease has distinct causes and treatments. Early diagnosis via echocardiography and ECG is crucial for managing PHT and preventing long-term disability.

Area of Science:

  • Cardiology
  • Pediatrics
  • Pulmonology

Background:

  • Pulmonary hypertension (PHT) is a common complication of untreated congenital heart disease (CHD).
  • Understanding the different pathophysiological mechanisms of PHT in CHD is essential for appropriate management.
  • Dual cardiac and respiratory pathology can complicate the diagnosis and treatment of PHT in children.

Purpose of the Study:

  • To review the causes, mechanisms, investigations, and therapies for PHT in congenital heart disease.
  • To differentiate between PHT resulting from increased pulmonary blood flow and elevated pulmonary vascular resistance.
  • To highlight the role of echocardiography and electrocardiography (ECG) in diagnosing PHT.

Main Methods:

  • Review of existing literature on pulmonary hypertension in congenital heart disease.
  • Discussion of diagnostic tools including echocardiography and ECG.
  • Analysis of treatment strategies based on PHT etiology.

Main Results:

  • PHT due to high pulmonary blood flow is treatable with surgical or catheter intervention.
  • PHT due to high pulmonary vascular resistance (Eisenmenger syndrome) requires palliative treatment or transplantation.
  • Early recognition and management of PHT can prevent long-term disability.

Conclusions:

  • Differentiating PHT causes is critical for guiding treatment in congenital heart disease.
  • Multidisciplinary collaboration between cardiac and respiratory specialists is often necessary.
  • Advances in assessment and treatment offer improved outcomes for children with PHT.

More Related Videos

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: